CompletedNCT03869736
Nitrous Oxide for Major Depression
About this title
Read the official source — NCT03869736Medication studyAges 18+United States + Australia
Understand this study
Who was this study for?
This study was for people with depression. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- Chicago and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: January 22, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 81
- Sponsor
- Bayside Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States, Australia
- Age range
- Over 18 Years
- Official registry ID
- NCT03869736
- Official title
Show the full official title
Evaluation of the Antidepressant Effects of Nitrous Oxide in People With Major Depressive Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chicago, United States · Melbourne, Australia
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Bayside Health.
Did this study involve medication?
Yes. The study involved medication, including Nitrous Oxide and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: from 18 years. Other eligibility criteria applied.
